Media Inquiries

The ADDF's science team includes experts in Alzheimer's disease and related dementias, neuroscience, geriatric medicine, drug discovery, and dementia prevention. They are available for comment on breaking news stories, research trends, and other topics.

To connect with an expert on staff, please contact Krishna Knabe, Director of Communications, at 212.901.7997.

Media Releases

January 10, 2017

Mark Roithmayr Appointed As Our First CEO

January 9, 2017

$2.5 Million in New Grants Advance Clinical Trials of Alzheimer's Treatments

November 15, 2016

Donald Newhouse Honored for His Efforts to End a Rare Form of Dementia

November 8, 2016

$1.5 Million in New Grant Funding for Promising Treatments

Print